Jefferies Raises Price Target on DexCom (DXCM) 40% After Q4 Results

Article Stock Quotes (1) Comments (0)

Jefferies boosted its price target DexCom (NASDAQ: DXCM) from $10 to $14 and reiterated its Buy rating following Q4 results.

The firm comments, "DXCM preannounced 4Q results of $22.4mn, reflecting a strong seasonal uptick in sensor utilization. 2012 is shaping up to be a year of investment as the company sets the stage for the Gen4 sensor launch."

FY12 EPS was trimmed from ($0.57) to ($0.72).

For an analyst ratings summary and ratings history on DexCom click here. For more ratings news on DexCom click here.

Shares of DexCom closed at $11.19 yesterday, with a 52 week range of $6.75-$16.91.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• KeyBank Upgrades MDC Holdings (MDC); Cuts PulteGroup (PHM) & Ryland Group (RYL)
• Jefferies Raises Numbers on hhgregg (HGG), But Remains on Sidelines
• Microsoft (MSFT) Rally Not Over Says UBS; Raises PT to $40

Create E-mail Alert Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change

Related Entities

Jefferies & Co

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?